Altered endocannabinoid system gene expression in inflammatory bowel disease mucosa: New perspectives in inflammatory bowel disease management | Synapse
March 3, 2026Open Access
Altered endocannabinoid system gene expression in inflammatory bowel disease mucosa: New perspectives in inflammatory bowel disease management
Puntos clave
A notable impairment of the endocannabinoid system was found in inflammatory bowel disease.
The study highlights the potential of cannabinoids as a therapeutic approach in managing inflammatory bowel disease.
Further analyses on larger cohorts are necessary for understanding the gene expression changes.
The findings suggest new perspectives for future treatment modalities in managing inflammatory bowel disease.
Resumen
We found a significant impairment of the ECS in IBD patients. Further analyses on larger cohorts are needed for a better understanding of the potential of cannabinoids in managing IBD.